Cases 1 - 10 of 14
AstraZeneca AB et al v. Alkem Laboratories Limited et al
as 1:2022cv00354
Plaintiff:
AstraZeneca AB, AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP
Defendant:
Alkem Laboratories Limited and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2022cv00032
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd. and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Alkem Laboratories Ltd. et al
as 1:2021cv00824
Defendant:
Alkem Laboratories Ltd. and S&B Pharma, Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Bial - Portela & CA S.A. et al v Alkem Laboratories Limited et al
as 1:2021cv00186
Plaintiff:
Sunovion Pharmaceuticals Inc., Bial - Holding, S.A. and Bial - Portela & CA S.A.
Defendant:
S&B Pharma, Inc. and Alkem Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA. S.A. et al v. Alkem Laboratories Limited et al
as 1:2020cv00786
Plaintiff:
Bial - Holding, S.A., BIAL - PORTELA & CA. S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
S&B Pharma, Inc. and Alkem Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BIAL - PORTELA & CA S.A. et al v. Alkem Laboratories Limited et al
as 1:2018cv00304
Plaintiff:
BIAL - PORTELA & CA S.A. , Bial - Holding, S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Alkem Laboratories Limited and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Alkem Laboratories Limited et al
as 1:2018cv00089
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Alkem Laboratories Limited and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
